| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.019 | 0.8 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |